Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
Status: | Active, not recruiting |
---|---|
Conditions: | Blood Cancer, Lymphoma, Hematology |
Therapuetic Areas: | Hematology, Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 12/13/2018 |
Start Date: | August 2004 |
End Date: | January 2020 |
Establishing a Tumor Bank and Initial Analysis of Germline and Tumor-Related Genetic Alterations in Families With Multiple Lymphoproliferative Malignancies
The purpose of this study is to investigate possible genetic factors that contribute to the
development of lymphomas. The databank will be used to determine whether familial lymphomas
have unique genetic characteristics different from sporadic lymphomas and to attempt to
identify a gene that confers an increased risk of lymphoma.
development of lymphomas. The databank will be used to determine whether familial lymphomas
have unique genetic characteristics different from sporadic lymphomas and to attempt to
identify a gene that confers an increased risk of lymphoma.
- Patients who participate will be asked to complete detailed family and medical history
questionnaires initially, with a follow-up questionnaire every year.
- Patients will be asked to supply a blood sample and possibly a mouthwash sample, both of
which can be done by mail.
- Patients will be asked to consent to the release of their lymphoma tissue block for the
purposes of the study.
- Patients will be given letters of invitation for their affected relatives to invite them
to participate.
questionnaires initially, with a follow-up questionnaire every year.
- Patients will be asked to supply a blood sample and possibly a mouthwash sample, both of
which can be done by mail.
- Patients will be asked to consent to the release of their lymphoma tissue block for the
purposes of the study.
- Patients will be given letters of invitation for their affected relatives to invite them
to participate.
Inclusion Criteria:
- Any individual diagnosed with non-Hodgkin's lymphoma or Hodgkin's disease or chronic
lymphocytic leukemia (CLL), who has a 1st degree relative (parent, sibling or child)
with a lymphoproliferative disorder; or families in which the individual has a
lymphoproliferative disorder, and an unusual clustering of frequent or premature solid
tumors is also observed.
- Family members of the individual, either affected or unaffected with lymphoma, who are
contacted by the individual and agree to participate in the study.
- Deceased family members may be included in the study. Public records such as death
certificates may be used to confirm the history. Consent for medical records or tissue
blocks will be obtained from the deceased family member's next of kin. The hierarchy
of relatives defined as next of kin is spouse, offspring, parents and siblings.
Archived tissue samples may be used for genetic research.
- Age > 18 years
Exclusion Criteria:
- Subjects without a family history of lymphoma
We found this trial at
1
site
450 Brookline Ave
Boston, Massachusetts 2215
Boston, Massachusetts 2215
617-632-3000
Principal Investigator: Jennifer R. Brown, MD, PhD
Phone: 617-632-6692
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
Click here to add this to my saved trials